secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001493152-23-032095
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX director Michael H. May will not stand for re-election at December 2023 annual meeting
--------------------------------------------------------------------------------

- Dr. May cited need to reduce external commitments; no disagreement with AgeX.
- He serves on Audit, Compensation, and Nominating and Corporate Governance committees.
- His departure is effective upon the annual meeting expected in December 2023.
- No replacement named; board composition will change at that time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223032095/0001493152-23-032095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223032095/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer